RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
46.77
+0.73 (1.59%)
At close: Jul 19, 2024, 4:00 PM
46.82
+0.05 (0.11%)
Pre-market: Jul 22, 2024, 7:10 AM EDT

RxSight Revenue

RxSight had revenue of $101.10M in the twelve months ending March 31, 2024, with 75.67% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $29.51M with 68.75% year-over-year growth. In the year 2023, RxSight had annual revenue of $89.08M with 81.77% growth.

Revenue (ttm)
$101.10M
Revenue Growth
+75.67%
P/S Ratio
18.03
Revenue / Employee
$270,324
Employees
374
Market Cap
1.82B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202389.08M40.07M81.77%
Dec 31, 202249.01M26.41M116.90%
Dec 31, 202122.59M7.92M53.92%
Dec 31, 202014.68M12.44M554.98%
Dec 31, 20192.24M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 617.51M
NeoGenomics 610.66M
Veracyte 375.47M
Zai Lab 291.07M
Mirum Pharmaceuticals 224.00M
Ligand Pharmaceuticals 118.31M
Keros Therapeutics 234.00K
Revenue Rankings